Seroprevalence of infection-induced SARS-CoV-2 antibodies among health care users of Northern Italy: results from two serosurveys (October-November 2019 and September-October 2021)Article Published on 2022-11-012022-11-15 Journal: International Journal of Infectious Diseases [Category] SARS, 진단, 치료기술, [키워드] 95% CI 95% confidence interval age anti-Nucleocapsid IgG antibodies antibody calculated Care circulating CIs conducted COVID-19 detect domains enzyme-linked immunosorbent enzyme-linked immunosorbent assay Gender groups Health Hypothesis IgG IgG antibody Immunoglobulin immunosorbent Italy multiplex nucleocapsid Piedmont positive test result prevalence rate proportion Receptor binding domain Result S1 and S2 S1 domain Sample SARS-CoV-2 SARS-CoV-2 antibody semiquantitative method sera Seroprevalence Serosurvey Support tested the spike protein Transmission dynamics virus [DOI] 10.1016/j.ijid.2022.09.017 PMC 바로가기
SARS-CoV-2 dual infection with Delta and Omicron variants in an immunocompetent host: a case reportArticle Published on 2022-11-012022-11-15 Journal: International Journal of Infectious Diseases [Category] SARS, 변종, 치료기술, [키워드] Admission Analysis Case report caused Contamination coronary syndrome COVID-19 Delta detect discharged dominant variant Dual infection expected highlight hospital Hospitalized Infection Lineage Mild symptom omicron Patient positive test result reported SARS-CoV-2 SARS-CoV-2 infections SARS-CoV-2 RNA sequence sequenced Sequencing Single-genome sequencing. the SARS-CoV-2 variant variants virus whole genome [DOI] 10.1016/j.ijid.2022.08.027 PMC 바로가기
Monitoring of SARS-CoV-2 circulation using saliva testing in school children in Rome, ItalyArticle Published on 2022-11-012022-11-15 Journal: International Journal of Infectious Diseases [Category] SARS, 치료기술, [키워드] analyzed anticipated Asymptomatic children circulation collected COVID-19 COVID-19 diagnosis Isolation Italy Laboratory Local Molecular assay MONITOR monitoring Nasopharyngeal swab nine NPs NPSs Population positive positive test result representing Rome Saliva saliva sample saliva samples SARS-CoV-2 SARS-CoV-2 RNA School Surveillance System tested virus transmission [DOI] 10.1016/j.ijid.2022.09.007 PMC 바로가기
Palmitoylethanolamide Reduces Proinflammatory Markers in Unvaccinated Adults Recently Diagnosed with COVID-19: A Randomized Controlled TrialArticle Published on 2022-10-062022-11-15 Journal: The Journal of Nutrition [Category] COVID19(2023년), SARS, 바이오마커, [키워드] adhesion molecules age anti-inflammatory effect Antigen assigned baseline Biomarker Blood BMI C-reactive protein CDC chronic condition coin toss Concentration conducted Controlled coronavirus disease covariates COVID-19 COVID-19 complications COVID-19, SARS-COV-2 Cytokines diagnosed with COVID-19 Diagnosis dietary supplements double-blind dysregulated immune response Effect exacerbate ferritin group Health IL-1β IL-2 IL-6 implicated indicated individual infected with COVID-19 infections infectious conditions Inflammation inflammatory mediator intercellular Linear regression model mechanism Multiple outcomes P-selectin palmitoylethanolamide participant Placebo placebo tablet positive test result Primary outcome produced proinflammatory promote randomized placebo-controlled trial Randomly receive reduced reported RT-PCR secretion severity Sex significantly stratified treatment effect [DOI] 10.1093/jn/nxac154 PMC 바로가기
COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 PeriodsArticle Published on 2022-10-032022-11-16 Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 변종, [키워드] addition age Antigen Asymptomatic booster children clinical symptom Community conducted cough COVID-19 COVID-19 symptom COVID-19 testing cross-sectional Delta Duration Evolution Fever first positive Fisher Health Isolation Latinx less loss of taste median myalgia negative test omicron outcome participant Participants Patient Period population immunity positive positive result positive test result Practitioner proportion public health Rapid remained repeated reported reported symptoms San Francisco SARS-COV-2 infection seeking Site sore throat Symptom symptom onset symptomatic symptomatic participant Symptoms Test tested Testing upper respiratory tract vaccination Vaccine variant Viral variants were used with COVID-19 worsening χ2 test [DOI] 10.1001/jamanetworkopen.2022.35844 PMC 바로가기
When to test for COVID-19 using real-time reverse transcriptase polymerase chain reaction: a systematic reviewReview article Published on 2022-10-012022-10-05 Journal: International Journal of Infectious Diseases [Category] 치료기술, [키워드] addition affected analyzed article Case series cohorts conducted coronavirus cough country COVID-19 COVID-19 testing Cross-sectional studies database described Dyspnea evaluate Fever first positive health units Infection initial symptom median age objective participant Patient patients polymerase chain positive positive test result real-time reverse transcriptase Real-time reverse transcriptase polymerase chain reaction reported Result retrospective cohorts RT-PCR RT-PCR test RT-PCR testing SARS-CoV-2 Symptom symptom onset systematic review the MEDLINE [DOI] 10.1016/j.ijid.2022.06.037 [Article Type] Review article
Low rate of SARS-CoV-2 incident infection identified by weekly screening PCR in a prospective year-long cohort studyArticle Published on 2022-09-262022-11-15 Journal: PLoS ONE [Category] SARS, 치료기술, [키워드] asymptomatic individual benefit close contact cohort study community transmission contribute detect eight identify incidence incident individual Infection nasal swab participant Participants PCR Population positive test result pre-symptomatic SARS-CoV-2 SARS-COV-2 infection seronegative significantly more submitted Surveillance Symptom symptomatic [DOI] 10.1371/journal.pone.0274078 PMC 바로가기
Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study주요 오미크론 BA.1 또는 오미크론 이전 SARS-CoV-2 감염에 의해 부여된 오미크론 (B.1.1.529) BA.2 재감염에 대한 보호: mRNA 백신 접종 여부에 따른 의료 종사자를 대상으로 한 검사 음성 사례 대조 연구Article Published on 2022-09-212022-10-06 Journal: The Lancet. Infectious Diseases [Category] SARS, 진단, [키워드] 95% CI B.1.1.529 benefit case-control study conducted Control database determine diagnosed dose doses Effect Genetic greater health-care Immunity inclusion criteria Infection infection risk Laboratory likelihood Lineage mRNA mRNA vaccination mRNA vaccine negative test nucleic acid amplification Older omicron paucity of data Positive test positive test result predominant Primary infection protection Quebec, Canada reduction in Regression model Reinfection risk reduction SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 test service study period tested vaccination vaccine dose variant variants was increased [DOI] 10.1016/S1473-3099(22)00578-3 PMC 바로가기 [Article Type] Article
Quantitative analysis of RT-PCR test results for SARS-CoV-2 diagnostics across Poland during COVID-19 pandemic: Comparison between early stage and major pandemic waves in 2020 and 2021 with reference to SARS-CoV-2 variantsArticle Published on 2022-09-012022-11-15 Journal: Advances in medical sciences [Category] SARS, 변종, 진단, 치료기술, [키워드] 95% confidence interval affected age amplification Analysis analysis of variance analyzed Bonferroni correction COVID-19 COVID-19 case cycle threshold diagnostic diagnostics difference displaying early stage Epidemiology exhibited First wave greater groups inaccuracy limit of detection molecular testing nucleic acid amplification test pandemic Patient patients Poland polymerase chain positive result positive test result ranged recorded reverse transcription risk RT-PCR RT-PCR test SARS-CoV-2 SARS-CoV-2 positive RT-PCR SARS-CoV-2 variant SARS-CoV-2 virus single center tested variant virus were used younger patient [DOI] 10.1016/j.advms.2022.09.002 PMC 바로가기
Agreement Between SARS-CoV-2 PCR Test Results Using Nasopharyngeal and Mid-Turbinate Specimens Among Asymptomatic Working-Age AdultsArticle Published on 2022-09-012022-11-15 Journal: Journal of occupational and environmental medicine [Category] COVID19(2023년), SARS, 치료기술, [키워드] agreement Asymptomatic COVID-19 cycle threshold Cycle threshold value decrease detect determine evaluated Infection initial nasopharyngeal PCR PCR testing positive positive result positive test result Qualitative reached reduced repeated Result risk SARS-COV-2 infection SARS-CoV-2 PCR specimen Swab Test Viral load [DOI] 10.1097/JOM.0000000000002620 PMC 바로가기